{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:22:32Z","timestamp":1790839352250,"version":"4.1.0"},"reference-count":91,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Austrian Science Fund (FWF)","award":["J-4102"],"award-info":[{"award-number":["J-4102"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Tenascin-C (TNC) is a complex glycoprotein of the extracellular matrix (ECM) involved in a plethora of (patho-)physiological processes, such as oncogenesis and inflammation. Since chemokines play an essential role in both disease processes, we have investigated here the binding of TNC to some of the key chemokines, namely CCL2, CCL26, CXCL8, CXCL10, and CXCL12. Thereby, a differential chemokine-TNC binding pattern was observed, with CCL26 exhibiting the highest and CCL2 the lowest affinity for TNC. Heparan sulfate (HS), another member of the ECM, proved to be a similarly high-affinity ligand of TNC, with a Kd value of 730 nM. Chemokines use glycosa-minoglycans such as HS as co-receptors to induce immune cell migration. Therefore, we assumed an influence of TNC on immune cell chemotaxis due to co-localization within the ECM. CCL26- and CCL2-induced mobilization experiments of eosinophils and monocytes, respectively, were thus performed in the presence and the absence of TNC. Pre-incubation of the immune cells with TNC resulted in a 3.5-fold increase of CCL26-induced eosinophil chemotaxis, whereas a 1.3-fold de-crease in chemotaxis was observed when monocytes were pre-incubated with CCL2. As both chemokines have similar HS binding but different TNC binding affinities, we speculate that TNC acts as an attenuator in monocyte and as an amplifier in eosinophil mobilization by impeding CCL2 from binding to HS on the one hand, and by reinforcing CCL26 to bind to HS on the other hand.<\/jats:p>","DOI":"10.3390\/ijms241914694","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:55:54Z","timestamp":1695880554000},"page":"14694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chemokine Binding to Tenascin-C Influences Chemokine-Induced Immune Cell Migration"],"prefix":"10.3390","volume":"24","author":[{"given":"Alissa","family":"Domaingo","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Schubertstr. 1, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Jokesch","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Schubertstr. 1, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Schweiger","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Schubertstr. 1, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8869-5924","authenticated-orcid":false,"given":"Martha","family":"Gschwandtner","sequence":"additional","affiliation":[{"name":"Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-9721","authenticated-orcid":false,"given":"Tanja","family":"Gerlza","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Schubertstr. 1, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-7814","authenticated-orcid":false,"given":"Manuel","family":"Koch","sequence":"additional","affiliation":[{"name":"Institute for Dental Research and Oral Musculoskeletal Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Joseph-Stelzmann-Str. 52, 50931 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim S.","family":"Midwood","sequence":"additional","affiliation":[{"name":"Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-797X","authenticated-orcid":false,"given":"Andreas J.","family":"Kungl","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Karl-Franzens-University Graz, Schubertstr. 1, 8010 Graz, Austria"},{"name":"Antagonis Biotherapeutics GmbH, Strasserhofweg 77a, 8045 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00441-009-0829-3","article-title":"Syndecans as receptors and organizers of the extracellular matrix","volume":"339","author":"Xian","year":"2010","journal-title":"Cell Tissue Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.109.001289","article-title":"Extracellular matrix molecules: Potential targets in pharmacotherapy","volume":"61","author":"Sainio","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"M111.014647","DOI":"10.1074\/mcp.M111.014647","article-title":"The matrisome: In silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices","volume":"11","author":"Naba","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Naba, A., Clauser, K.R., Whittaker, C.A., Carr, S.A., Tanabe, K.K., and Hynes, R.O. (2014). Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-518"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12079-009-0075-1","article-title":"The role of tenascin-C in tissue injury and tumorigenesis","volume":"3","author":"Midwood","year":"2009","journal-title":"J. Cell Commun. Signal."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1524-475X.2009.00466.x","article-title":"Interactions between extracellular matrix and growth factors in wound healing","volume":"17","author":"Schultz","year":"2009","journal-title":"Wound Repair Regen."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0945-053X(00)00106-2","article-title":"Tenascin-C in development and disease: Gene regulation and cell function","volume":"19","author":"Jones","year":"2000","journal-title":"Matrix Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/jcs.190546","article-title":"Tenascin-C at a glance","volume":"129","author":"Midwood","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/19336918.2014.987587","article-title":"Tenascin-C: Form versus function","volume":"9","author":"Giblin","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"ref_12","first-page":"488","article-title":"Tenascins: Regulation and putative functions during pathological stress","volume":"200","author":"Chiquet","year":"2003","journal-title":"J. Pathol. A J. Pathol. Soc. Great Br. Irel."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"834353","DOI":"10.3389\/fimmu.2021.834353","article-title":"Editorial for \u201cTenascins: Key Players in Tissue Homeostasis and Defense\u201d","volume":"5805","author":"Yoshida","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02602952","article-title":"The role of chemokines in inflammation","volume":"26","author":"Proost","year":"1996","journal-title":"Int. J. Clin. Lab. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1073\/pnas.0334864100","article-title":"Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines","volume":"100","author":"Proudfoot","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","first-page":"641","article-title":"Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity","volume":"110","author":"Stankovic","year":"2009","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.18-1-65","article-title":"The role of MCP-1 in atherosclerosis","volume":"18","author":"Harrington","year":"2000","journal-title":"Stem Cells"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mahad, D.J., and Ransohoff, R.M. (2003). The Role of MCP-1 (CCL2) and CCR2 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis (EAE), Elsevier.","DOI":"10.1016\/S1044-5323(02)00125-2"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: How CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wawrzyniak, D., Grabowska, M., G\u0142odowicz, P., Kuczy\u0144ski, K., Kuczy\u0144ska, B., Fedoruk-Wyszomirska, A., and Rolle, K. (2020). Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237889"},{"key":"ref_23","first-page":"8214","article-title":"Tenascin-C as a New Marker for the Diagnosis and Treatment Monitoring of Breast Cancer","volume":"8","author":"Shaker","year":"2021","journal-title":"NVEO-Nat. Volatiles Essent. Oils J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"620773","DOI":"10.3389\/fonc.2021.620773","article-title":"Macrophages and extracellular matrix in breast cancer: Partners in crime or protective allies?","volume":"11","author":"Deligne","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bbi.2019.06.047","article-title":"Tenascin C regulates multiple microglial functions involving TLR4 signaling and HDAC1","volume":"81","author":"Haage","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/19336918.2015.1008333","article-title":"Transcriptional regulation of tenascin genes","volume":"9","author":"Chiovaro","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.179.3.881","article-title":"Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation","volume":"179","author":"Jose","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.185.12.2171","article-title":"Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes","volume":"185","author":"Forssmann","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.0413189","article-title":"Are all eotaxins created equal?","volume":"94","author":"Pease","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/thorax.57.5.405","article-title":"Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema","volume":"57","author":"Tanino","year":"2002","journal-title":"Thorax"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.str.2011.06.001","article-title":"Oligomeric structure of the chemokine CCL5\/RANTES from NMR, MS, and SAXS data","volume":"19","author":"Wang","year":"2011","journal-title":"Structure"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2004.06.008","article-title":"Increased CXCL8 (IL-8) expression in Multiple Sclerosis","volume":"155","author":"Lund","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2249.1994.tb06109.x","article-title":"Expression of the chemokine superfamily in rheumatoid arthritis","volume":"97","author":"Hosaka","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1172\/JCI1195","article-title":"A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice","volume":"101","author":"Boisvert","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","article-title":"A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)","volume":"184","author":"Bleul","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jlb.66.2.252","article-title":"Regulation of dendritic cell trafficking: A process that involves the participation of selective chemokines","volume":"66","author":"Vicari","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_37","first-page":"3354","article-title":"Plasma elevation of stromal cell\u2013derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells","volume":"97","author":"Hattori","year":"2001","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/bbrc.1998.8499","article-title":"Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4\/fusin) under the control of autocrine activity and exogenous cytokines","volume":"247","author":"Feil","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1167\/iovs.07-1015","article-title":"Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: Implications for vasodegeneration in diabetic retinopathy","volume":"49","author":"Bhatwadekar","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.4049\/jimmunol.181.7.4632","article-title":"Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1\u03b1 through Lyn kinase","volume":"181","author":"Malik","year":"2008","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1189\/jlb.0908576","article-title":"Requirement of HMGB1 for stromal cell\u2013derived factor\u20131\/CXCL12\u2013dependent migration of macrophages and dendritic cells","volume":"86","author":"Campana","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1634\/stemcells.2005-0271","article-title":"Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases","volume":"24","author":"Son","year":"2006","journal-title":"Stem Cells"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e13270","DOI":"10.15252\/emmm.202013270","article-title":"Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression","volume":"13","author":"Murdamoothoo","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"jcs260244","DOI":"10.1242\/jcs.260244","article-title":"Advances on the roles of tenascin-C in cancer","volume":"135","author":"Yilmaz","year":"2022","journal-title":"J. Cell Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/elps.201600043","article-title":"Exploring the glycosaminoglycan-protein interaction network by glycan-mediated pull-down proteomics","volume":"37","author":"Gesslbauer","year":"2016","journal-title":"Electrophoresis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.72.121801.161747","article-title":"Regulation of Protein Function by Glycosaminoglycans\u2014As exemplified by Chemokines","volume":"74","author":"Handel","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1476-5381.2012.02089.x","article-title":"Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans","volume":"167","author":"Adage","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1242\/jcs.110.12.1413","article-title":"Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C","volume":"110","author":"Chung","year":"1997","journal-title":"J. Cell Sci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhu, H., Gan, H., Meng, Q., Du, G., An, Y., and Liu, J. (2020). The effect of heparan sulfate on promoting amyloid fibril formation by \u03b2-casein and their binding research with multi-spectroscopic approaches. J. Photochem. Photobiol. B Biol., 202.","DOI":"10.1016\/j.jphotobiol.2019.111671"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate\u2013protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1002\/1873-3468.13082","article-title":"The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration","volume":"592","author":"Chantepie","year":"2018","journal-title":"FEBS Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"155503","DOI":"10.1016\/j.cyto.2021.155503","article-title":"Glycosaminoglycans located on neutrophils and monocytes impact on CXCL8-and CCL2-induced cell migration","volume":"142","author":"Gerlza","year":"2021","journal-title":"Cytokine"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Pum, A., Ennemoser, M., Gerlza, T., and Kungl, A.J. (2022). The Role of Heparan Sulfate in CCL26-Induced Eosinophil Chemotaxis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126519"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zlotnik, A., Yoshie, O., and Nomiyama, H. (2006). The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol., 7.","DOI":"10.1186\/gb-2006-7-12-243"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Proudfoot, A.E. (2006). The biological relevance of chemokine-proteoglycan interactions. Biochem. Soc. Trans., 34.","DOI":"10.1042\/BST0340422"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Derler, R., Kitic, N., Gerlza, T., and Kungl, A.J. (2021). Isolation and Characterization of Heparan Sulfate from Human Lung Tissues. Molecules, 26.","DOI":"10.3390\/molecules26185512"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhou, Z.-H., Karnaukhova, E., Rajabi, M., Reeder, K., Chen, T., Dhawan, S., and Kozlowski, S. (2014). Oversulfated chondroitin sulfate binds to chemokines and inhibits stromal cell-derived factor-1 mediated signaling in activated T cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094402"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1074\/jbc.M200396200","article-title":"Oversulfated Chondroitin\/Dermatan Sulfates Containing GlcA\u03b21\/IdoA\u03b11\u20133GalNAc (4,6-O-disulfate) Interact with L-and P-selectin and Chemokines*","volume":"277","author":"Kawashima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbagen.2008.09.001","article-title":"Glycosaminoglycan affinity of the complete fibroblast growth factor family","volume":"1790","author":"Asada","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1074\/jbc.273.25.15487","article-title":"Defining the interleukin-8-binding domain of heparan sulfate","volume":"273","author":"Spillmann","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Imanaka-Yoshida, K. (2021). Tenascin-C in Heart Diseases\u2014The Role of Inflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115828"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/BSR20130069","article-title":"Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo","volume":"33","author":"Falsone","year":"2013","journal-title":"Biosci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/protein\/gzv025","article-title":"Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity","volume":"28","author":"Gerlza","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/jcb.27681","article-title":"Extracellular matrix (ECM) stiffness and degradation as cancer drivers","volume":"120","author":"Najafi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2014.01.007","article-title":"Tenascins in stem cell niches","volume":"37","author":"Orend","year":"2014","journal-title":"Matrix Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/CritRevImmunol.v31.i2.30","article-title":"Expression and immune function of tenascin-C","volume":"31","author":"Udalova","year":"2011","journal-title":"Crit. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcp.20527","article-title":"Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase\/Akt-dependent and mediated by Ets family transcription factors","volume":"206","author":"Jinnin","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_68","first-page":"377","article-title":"Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II","volume":"141","author":"Mackie","year":"1992","journal-title":"Am. J. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1242\/jcs.113.20.3583","article-title":"Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle","volume":"113","author":"Chiquet","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00018-011-0783-6","article-title":"Advances in tenascin-C biology","volume":"68","author":"Midwood","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"577015","DOI":"10.3389\/fimmu.2020.577015","article-title":"Tenascin-C in osteoarthritis and rheumatoid arthritis","volume":"11","author":"Hasegawa","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/annrheumdis-2015-208495","article-title":"Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis","volume":"75","author":"Schwenzer","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/cncr.11796","article-title":"Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma","volume":"98","author":"Leins","year":"2003","journal-title":"Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1073\/pnas.84.13.4621","article-title":"Tenascin is a stromal marker for epithelial malignancy in the mammary gland","volume":"84","author":"Mackie","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/19336918.2015.1008332","article-title":"Tenascin-C and integrins in cancer","volume":"9","author":"Yoshida","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.addr.2015.12.017","article-title":"The extracellular matrix in breast cancer","volume":"97","author":"Oskarsson","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19336918.2015.1008331","article-title":"Tenascin C in metastasis: A view from the invasive front","volume":"9","author":"Lowy","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cmi.2017.134","article-title":"Chemokines in homeostasis and diseases","volume":"15","author":"Chen","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Donovan, C., Bai, X., Chan, Y.L., Feng, M., Ho, K.-F., Guo, H., Chen, H., and Oliver, B.G. (2023). Tenascin C in Lung Diseases. Biology, 12.","DOI":"10.3390\/biology12020199"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcdb.2022.03.019","article-title":"Tenascin-C in fibrosis in multiple organs: Translational implications","volume":"128","author":"Bhattacharyya","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.drudis.2021.12.004","article-title":"Chemokines and chemokine receptors in inflammatory bowel disease: Recent findings and future perspectives","volume":"27","author":"Arosa","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gencer, S., Evans, B.R., van der Vorst, E.P.C., D\u00f6ring, Y., and Weber, C. (2021). Inflammatory Chemokines in Atherosclerosis. Cells, 10.","DOI":"10.3390\/cells10020226"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Gschwandtner, M., Gammage, A.N., Deligne, C., Mies, L.F.M., Domaingo, A., Murdamoothoo, D., Loustau, T., Schwenzer, A., Derler, R., and Carapito, R. (2023). Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098365"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1038\/s41467-021-27108-8","article-title":"High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer","volume":"12","author":"Rogic","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.pmbts.2019.11.007","article-title":"Chapter Four\u2014Prediction and targeting of GPCR oligomer interfaces","volume":"Volume 169","author":"Giraldo","year":"2020","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2020.03.003","article-title":"Impact of GPCR Structures on Drug Discovery","volume":"181","author":"Congreve","year":"2020","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.3390\/molecules190710618","article-title":"A Combinatorial Approach to Biophysically Characterise Chemokine-Glycan Binding Affinities for Drug Development","volume":"19","author":"Gerlza","year":"2014","journal-title":"Molecules"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4899-1079-0_2","article-title":"Structural information on proteins from circular dichroism spectroscopy possibilities and limitations","volume":"7","author":"Bloemendal","year":"1995","journal-title":"Phys. Methods Charact. Pharm. Proteins"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"154942","DOI":"10.1016\/j.cyto.2019.154942","article-title":"PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo","volume":"127","author":"Gerlza","year":"2020","journal-title":"Cytokine"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:00:44Z","timestamp":1760130044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":91,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms241914694"],"URL":"https:\/\/doi.org\/10.3390\/ijms241914694","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}